Early Pregnancy · Loss
Recurrent Miscarriage — Workup & Next Steps
Recurrent miscarriage is hard. Here's the full workup, what's treatable (especially antiphospholipid syndrome — aspirin + LMWH lifts live-birth rate from ~10% to ~70-80%), and what next pregnancy looks like. ESHRE 2022 / RCOG / NICE NG126.
Last reviewed 1 June 2026
ESHRE 2022 + RCOG 17 + ASRM 2020
Additional context (tick all that apply)
Troubleshooting + common pitfalls
- Pitfall: Waiting for 3 losses before any workup.
Solution: ESHRE 2022 + ASRM 2020 lowered the trigger to 2 losses. RCOG 2023 still uses 3 but recognises 2 with risk factors. Don’t leave couples in repeated cycles of unexplained loss before offering investigation. - Pitfall: Diagnosing APS on a single positive test.
Solution: APS requires TWO positive tests ≥ 12 weeks apart (Sydney criteria 2006). Single positive may be transient (post-viral, drug-induced) and doesn’t justify pregnancy-long LMWH + aspirin. - Pitfall: Testing inherited thrombophilia for early miscarriages.
Solution: ESHRE 2022 advises AGAINST routine thrombophilia testing for first-trimester recurrent loss — evidence does NOT support LMWH benefit in this scenario (ALIFE 2010, SPIN 2014 trials negative). Reserve for second-trimester losses or thrombosis history. - Pitfall: Septum resection for everyone with septate uterus.
Solution: TRUST trial (Rikken NEJM 2021) didn’t show benefit overall — individualise based on septum length, loss pattern, and patient preference. Don’t default to surgery. - Pitfall: Progesterone given to all RM women.
Solution: PROMISE (NEJM 2015) negative overall. PRISM (NEJM 2019) showed benefit only in the subgroup with 3+ prior losses + CURRENT bleed. Don’t prescribe universally. - Pitfall: Skipping POC cytogenetics.
Solution: 50–70 % of sporadic miscarriages are aneuploid; POC cytogenetics on next loss avoids unnecessary further workup if abnormal embryo is the explanation. Microarray > G-banding (avoids maternal cell contamination). - Pitfall: Not addressing modifiable risk factors.
Solution: Smoking, alcohol (any), BMI > 30 or < 18.5, uncontrolled diabetes, untreated hypothyroidism each independently raise miscarriage risk. Address these BEFORE expensive workup. - Pitfall: No counselling on natural prognosis.
Solution: Even with unexplained RM, ~60–70 % live birth rate in the NEXT pregnancy with supportive care alone. Tell couples this number — it’s often more reassuring than test results. - Pitfall: Aspirin/LMWH for unexplained RM.
Solution: ALIFE and SPIN trials showed NO benefit of aspirin or LMWH in unexplained RM. Reserve for confirmed APS. - Pitfall: Forgetting partner factor.
Solution: Parental karyotyping covers both partners (~2–5 % balanced translocation rate, often paternal). Semen analysis if subfertility coexists. - Pitfall: No psychological support.
Solution: RM carries depression, anxiety, PTSD risk similar to stillbirth. Offer specialist counselling regardless of investigation results. - Pitfall: Investigations without a pre-conception plan.
Solution: Tie results to a documented next-pregnancy plan: lifestyle, supplements, early reassurance scans, treatment of identified cause, expectant management for unexplained.
What counts as recurrent miscarriage?
Definitions vary by guideline:
- ESHRE 2022 / ASRM 2020: ≥2 pregnancy losses (consecutive or not) before 24 weeks (ESHRE) / 20 weeks (ASRM).
- RCOG 2023: retains ≥3 consecutive losses but agrees workup reasonable after 2 in selected scenarios.
The trend internationally is toward earlier intervention. You don’t have to wait until 3 — ask your GP for referral to recurrent miscarriage clinic after 2 losses if you want.
Why does miscarriage happen?
Single miscarriage: most often random chromosomal abnormality in the embryo (~50-70% of first-trimester losses); doesn’t repeat.
Recurrent miscarriage causes (after workup):
- Antiphospholipid syndrome (~15%) — autoimmune clotting, very treatable.
- Uterine structural issues (~10-15%) — septum, fibroids, adhesions.
- Genetic — parental chromosomal translocation (~3-5%).
- Endocrine — uncontrolled diabetes, thyroid, low progesterone.
- Unexplained (~50%) — even after full workup.
Unexplained is hard emotionally but prognosis is good — 60-70% of next pregnancies are successful with supportive care.
The workup
ESHRE 2022 / RCOG GTG 17 (2023):
- Antiphospholipid antibodies (LA, aCL, anti-β2-GP1) — repeated 12 weeks later if positive.
- Thyroid function + HbA1c.
- Karyotyping of both parents if 2-3+ losses.
- Pelvic ultrasound ± hysteroscopy.
- Lifestyle assessment (BMI, smoking, alcohol, caffeine).
Inherited thrombophilia testing NOT routine for first-trimester losses.
Antiphospholipid syndrome (APS)
The MOST TREATABLE cause of recurrent miscarriage.
Two positive antibody tests ≥12 weeks apart (Sydney criteria 2006): LA, aCL IgG/IgM, anti-β2-GP1 IgG/IgM.
Treatment: low-dose aspirin (75-100 mg/day) + LMWH injections from positive pregnancy test through 6 weeks postpartum.
Live birth rate rises from ~10% untreated to ~70-80% with aspirin + LMWH (Empson Cochrane 2005, Mak meta-analysis 2010).
Progesterone — does it help?
- PROMISE 2015: NO benefit in unexplained recurrent miscarriage.
- PRISM 2019: benefit ONLY in subgroup with 3+ prior losses + CURRENT first-trimester bleeding.
- NICE NG126: micronised vaginal progesterone for that specific group only.
Don’t prescribe universally.
Prognosis
Even after 2-3 losses, 60-70% of next pregnancies are successful with supportive care. Even unexplained recurrent miscarriage has reasonable prognosis.
Key: appropriate workup, treat what’s found, supportive next-pregnancy care (early scans for reassurance).
Different scenarios — recurrent miscarriage
Scenario 1: Two consecutive losses, otherwise healthy, age 28
Ask GP for recurrent miscarriage referral. Workup: APS antibodies, thyroid, HbA1c, pelvic US. Lifestyle review. Try again in own timing once any treatable issue addressed.
Scenario 2: Three losses, APS antibodies positive
Diagnosis confirmed: APS. Treatment plan ready for next pregnancy: aspirin + LMWH from positive test. Live birth rate rises from ~10% to ~70-80%. Recurrent miscarriage clinic care.
Scenario 3: Three losses, all workup normal (unexplained)
Prognosis: 60% next pregnancy successful with supportive care. Early scans for reassurance. Continued GP/clinic support. Counselling for grief and anxiety.
Scenario 4: Late second-trimester loss
Different workup — cervical incompetence assessment, infection screen, inherited thrombophilia testing IS appropriate here. Cervical cerclage possibly indicated next pregnancy. Specialist care.
Scenario 5: Recurrent miscarriage + advanced maternal age 40
Add chromosomal contribution (egg quality declines). Workup as usual. May consider IVF / PGT-A. Realistic timeline discussion with fertility specialist.
Care guidance — recurrent miscarriage
- Ask for referral after 2 losses if you want.
- Workup before next pregnancy — many tests need timing.
- Treat anything found (APS, structural, endocrine).
- Lifestyle optimisation — BMI, smoking, alcohol, caffeine, folic acid.
- Partner contribution — karyotype, lifestyle.
- Emotional support — Tommy’s, Sands, Miscarriage Association.
- Counselling — GP referral or private.
- Try again in YOUR timing — not external pressure.
- Early scans for reassurance in next pregnancy.
- Mental health screening at booking, 28 weeks, postpartum.
- Don’t blame yourself — recurrent miscarriage rarely caused by anything you did.
Sources
- ESHRE Guideline Group. ESHRE guideline: recurrent pregnancy loss 2022.
- RCOG Green-top Guideline 17. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage.
- NICE NG126. Ectopic pregnancy and miscarriage: diagnosis and initial management.
- Coomarasamy A, et al. PROMISE trial. NEJM 2015.
- Coomarasamy A, et al. PRISM trial. NEJM 2019.
- Empson M, et al. Cochrane Review: aspirin + heparin in antiphospholipid antibody recurrent miscarriage.
- Miscarriage Association UK. Recurrent miscarriage support.
Recommended for this calculator